# OnCo record captain-t-cell (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/captain-t-cell/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "captain-t-cell" ;
  schema:name "Captain T Cell"@en ;
  schema:description "Captain T Cell is a German company that engineers a patient's T cells with a receptor that recognises a protein called MAGE-A4 on some solid tumours, with extra changes meant to help the cells keep working inside a tumour. Its first product was heading into a first-in-human trial at German university hospitals in 2025."@en ;
  schema:url <https://onco.cc/companies/captain-t-cell/>, <https://www.captaintcell.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.captaintcell.com/>, <https://www.mdc-berlin.de/news/news/captain-t-cell-secures-seed-financing-round>, <https://www.captaintcell.com/news/captain-t-cell-closes-financing-round-to-advance-tcr-t-pipeline-into-clinic>, <https://www.captaintcell.com/news/clinical-development-update> ;
  schema:addressCountry "DE" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/urothelial/>, <https://onco.cc/cancers/gastric/>, <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/head-and-neck/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/tcr-t/>, <https://onco.cc/technologies/allogeneic-cell-therapy/> ;
  onco:targets <https://onco.cc/targets/mage-a4/> .